August 29, 2016, the world's leading healthcare company Abbott announced that its R & D Auxiliary good sense of instant scan glucose monitoring system --FreeStyle Libre has been listed China China Food and Drug Administration (CFDA) approval.
It is understood that this revolutionary technology has completely subverted the traditional fingertip blood collection monitoring methods and relieved the pain and inconvenience. The new technology enables real-time, accurate blood glucose monitoring through sensors placed on the outside of the upper part of the arm, greatly simplifying the blood glucose monitoring process in China's diabetic population and further improving their quality of life.
The breakthrough Abbott Affinity Scanning Glucose Monitoring System consists of a compact (slightly larger than a dollar coin) disposable circular sensor (comprising a flexible probe approximately 5 mm long) with a handheld scanning detector and Auxiliary and good sense software.
The user simply attaches the sensor with the probe to the outside of the upper part of the arm and monitors the glucose level in the interstitial fluid by inserting a subcutaneous probe to monitor the glucose level in real time. When the user places the handheld handheld scanner on top of the sensor, the scanner automatically acquires the current glucose data and provides 8 hours of historical glucose data and glucose trends. No blood collection and calibration are required in the whole process, and data can be read at any time according to the needs, eliminating the pain and inconvenience caused by traditional fingertip blood collection.
A sensor can be worn continuously for 14 days, after which a new sensor can be purchased as needed, and the scan detector can store up to 90 days of glucose data. At the same time, the system software can generate easy-to-understand reports and 24-hour dynamic glucose maps for users and doctors to understand the user's blood sugar changes, thus providing a reliable reference for the development of more accurate personalized treatment options.
According to the latest data from the World Health Organization, the number of diabetic patients in China is about 110 million, accounting for about one-tenth of the total number of Chinese adults, and the number of patients is rising and becoming younger. Diabetes has become one of the most challenging public health problems in China, and the situation is very serious. Blood glucose monitoring is a key part of diabetes management and its importance cannot be ignored.
But according to a recent study conducted by Abbott and the Chinese Medical Association, at least 74% of people with diabetes who are interviewed are unable to follow the blood glucose monitoring frequency recommended by the national guidelines. Low attention, inconvenient monitoring, and painful blood collection are the main reasons for poor compliance with blood glucose monitoring.
“How to enable patients to achieve blood glucose monitoring in a more convenient and comfortable environment, so that monitoring is no longer an 'disturbing'? This is what we have been working on,†said Eric Shroff, vice president of Asia Pacific Business Operations, Abbott Diabetes Products Business. "So we developed this epoch-making transient scanning glucose monitoring system. It eliminates the pain of blood collection at the fingertips of patients, and it is also perfectly integrated into daily life, which enhances their operational feasibility and willingness. It can provide a reliable reference for patients when they get a treatment plan, and will help them achieve a wonderful life through a healthy body."
At present, the Auxiliary System has been listed in 26 countries, including several European countries and Australia, Brazil and other countries, benefiting more than 120,000 people with diabetes. It is expected that this product will also be officially sold in the Chinese market by the end of this year.
Pet Supplies,Dog Harness,Dog Harness Vest,Large Dog Harness
YIWU CHUANGCHENG IMPORT&EXPORT CO.,LTD , https://www.tradingsix.com